UK interventions to control medicines wastage: a critical review - May 2010

By Nick Willson  Wednesday, 16. June 2010

The ADSHG, with the support of its clinical advisory panel, has been attempting to raise medical awareness of the risks to patient safety from short-term repeats (28-day repeat prescribing) for people with Addison's for several years. Now, we have also published an article showing that short-term repeats are not cost effective for patients on stable, long-term therapies such as steroid replacement treatment.

In June 2010, the International Journal of Pharmacy Practice published the ADSHG's article "UK interventions to control medicines wastage: a critical review".

Read the abstract on their website here...

This follows from our earlier published letters and public submissions, which have been:

• A letter to the British Medical Journal in 2007, which you can find at (Rapid Response to: BMJ BMJ 2007; 334: 1076-a).

• Submissions to the Gilmore Review of prescription charges pointing out that 28-day repeats imposed unnecessary pharmacy charges as well as meaning that steroid-dependent patients were at greater risk of running out of their essential medications. You can read these submissions on our website here..